SixPeaks Bio is developing a pipeline of medicines for healthy weight loss.
SixPeaks Bio has raised $80.0M in total funding. The most recent round was Debt Financing. The last funding was announced in May 2024.
SixPeaks Bio's investors include AstraZeneca, Versant Ventures.
SixPeaks Bio is headquartered in Basel, Switzerland.
SixPeaks Bio is developing a pipeline of medicines for healthy weight loss.
SixPeaks Bio is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SixPeaks Bio — Funding & Investors." VCBacked, May 22, 2024, https://www.vcbacked.co/company/sixpeaks-bio. Accessed September 30, 2026.
VCBacked. (2024). SixPeaks Bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/sixpeaks-bio
{{cite web |title=SixPeaks Bio — Funding & Investors |url=https://www.vcbacked.co/company/sixpeaks-bio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated